Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.

Logsdon NJ, Eberhardt MK, Allen CE, Barry PA, Walter MR.

PLoS One. 2011;6(11):e28127. doi: 10.1371/journal.pone.0028127. Epub 2011 Nov 21.

2.

Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.

Yue Y, Barry PA.

Adv Virus Res. 2008;72:207-26. doi: 10.1016/S0065-3527(08)00405-3. Review.

PMID:
19081492
3.

Exploiting viral natural history for vaccine development.

Barry PA.

Med Microbiol Immunol. 2015 Jun;204(3):255-62. doi: 10.1007/s00430-015-0406-1. Epub 2015 Mar 21. Review.

4.

Using the nonhuman primate model of HCMV to guide vaccine development.

Deere JD, Barry PA.

Viruses. 2014 Mar 27;6(4):1483-501. doi: 10.3390/v6041483. Review.

5.

Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease.

Wang D, Fu TM.

Curr Opin Virol. 2014 Jun;6:13-23. doi: 10.1016/j.coviro.2014.02.004. Epub 2014 Mar 14. Review.

PMID:
24632198
6.

Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.

Fu TM, An Z, Wang D.

Vaccine. 2014 May 7;32(22):2525-33. doi: 10.1016/j.vaccine.2014.03.057. Epub 2014 Mar 28. Review.

PMID:
24681264
7.

Pathogen manipulation of cIL-10 signaling pathways: opportunities for vaccine development?

Eberhardt MK, Barry PA.

Curr Top Microbiol Immunol. 2014;380:93-128. doi: 10.1007/978-3-662-43492-5_5. Review.

PMID:
25004815

Supplemental Content

Support Center